Lupus nephritis long-term study
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study follows patients with lupus nephritis (kidney inflammation caused by lupus) over time to learn more about the disease and improve care. You may join if you have had a kidney biopsy confirming lupus nephritis at this hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of lupus nephritis through a kidney biopsy at this hospital.
- You must be 14 years old or older.
- You must agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the kidneys survive over time in people with lupus nephritis. It uses medical records from the past 2–5 years to understand what affects kidney health.
This study looks at two simple blood tests to predict whether people with lupus nephritis (a kidney disease caused by lupus) may need intensive care or have a higher risk of dying in the hospital. It aims to help doctors identify who needs closer monitoring.
This study tests a care pathway for people with lupus-related kidney disease. It aims to provide better follow-up and treatment through telemedicine visits.
This study looks at tiny structures made by white blood cells, called neutrophil extracellular traps, in people with lupus kidney disease. It aims to understand their role and may lead to better treatments.
This study looks at a simple urine test to see if it can show how active lupus nephritis (kidney inflammation caused by lupus) is. It might help doctors monitor the condition without needing repeated biopsies.
This trial tests two biologic drugs (belimumab or telitacicept) compared to a standard treatment (mycophenolate mofetil) for people with active lupus nephritis. The goal is to see if biologics work better at controlling kidney inflammation over 6 months.
Hear when a new Lupus Nephritis (LN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.